TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.
Lee YU, de Dios Ruiz-Rosado J, Mahler N, Best CA, Tara S, Yi T, Shoji T, Sugiura T, Lee AY, Robledo-Avila F, Hibino N, Pober JS, Shinoka T, Partida-Sanchez S, Breuer CK.
Lee YU, et al. Among authors: mahler n.
FASEB J. 2016 Jul;30(7):2627-36. doi: 10.1096/fj.201500179R. Epub 2016 Apr 8.
FASEB J. 2016.
PMID: 27059717
Free PMC article.
Furthermore, blocking monocyte activation by TGF-betaR1 inhibition provides a viable strategy for preventing TEVG stenosis while maintaining neotissue formation.-Lee, Y.-U., de Dios Ruiz-Rosado, J., Mahler, N., Best, C. A., Tara, S., Yi, T., Shoji, T., Sugiura, T., …
Furthermore, blocking monocyte activation by TGF-betaR1 inhibition provides a viable strategy for preventing TEVG stenosis while maintaining …